What is SAB Biotherapeutics, Inc. Common Stock's Market Cap?

SAB Biotherapeutics, Inc. Common Stock's Market Cap is $323.4M, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Enterprise Value?

SAB Biotherapeutics, Inc. Common Stock's Enterprise Value is $224.0M, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's EV / EBITDA?

SAB Biotherapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Revenue (TTM)?

SAB Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Net Income (TTM)?

SAB Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$12.8M, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's EBITDA?

SAB Biotherapeutics, Inc. Common Stock's EBITDA is -$68.8M, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?

SAB Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.14, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Net Debt?

SAB Biotherapeutics, Inc. Common Stock's Net Debt is -$99.4M, based on as-reported figures from SEC (XBRL) filings.

SAB Biotherapeutics, Inc. Common Stock (SABS) Financial Statements

SAB Biotherapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00YHY0GX0

XNAS · usd

3.55▼ 0.08 (-2.08%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close3.63

Day's Range3.62 – 3.75

52-Week Range1.85 – 5.15

Volume170.8K

Avg Volume334.8K

Share Statistics

Shares Outstanding

Employees86

ExchangeXNAS

Listed2021-10-22

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about SAB Biotherapeutics, Inc. Common Stock (SABS)

What is SAB Biotherapeutics, Inc. Common Stock's Market Cap?: SAB Biotherapeutics, Inc. Common Stock's Market Cap is $323.4M, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Enterprise Value?: SAB Biotherapeutics, Inc. Common Stock's Enterprise Value is $224.0M, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's EV / EBITDA?: SAB Biotherapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Revenue (TTM)?: SAB Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Net Income (TTM)?: SAB Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$12.8M, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's EBITDA?: SAB Biotherapeutics, Inc. Common Stock's EBITDA is -$68.8M, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?: SAB Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.14, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Net Debt?: SAB Biotherapeutics, Inc. Common Stock's Net Debt is -$99.4M, based on as-reported figures from SEC (XBRL) filings.